Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Intangibles (2016 - 2025)

Historic Intangibles for Sanofi (SNYNF) over the last 14 years, with Q4 2025 value amounting to $30.6 billion.

  • Sanofi's Intangibles rose 2642.74% to $30.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $30.6 billion, marking a year-over-year increase of 2642.74%. This contributed to the annual value of $29.7 billion for FY2025, which is 2117.15% up from last year.
  • Per Sanofi's latest filing, its Intangibles stood at $30.6 billion for Q4 2025, which was up 2642.74% from $24.2 billion recorded in Q4 2024.
  • Sanofi's 5-year Intangibles high stood at $30.6 billion for Q4 2025, and its period low was $22.1 billion during Q4 2022.
  • For the 5-year period, Sanofi's Intangibles averaged around $25.5 billion, with its median value being $24.5 billion (2021).
  • Its Intangibles has fluctuated over the past 5 years, first tumbled by 984.46% in 2022, then skyrocketed by 2642.74% in 2025.
  • Over the past 5 years, Sanofi's Intangibles (Quarter) stood at $24.5 billion in 2021, then decreased by 9.84% to $22.1 billion in 2022, then rose by 18.51% to $26.2 billion in 2023, then fell by 7.58% to $24.2 billion in 2024, then grew by 26.43% to $30.6 billion in 2025.
  • Its Intangibles was $30.6 billion in Q4 2025, compared to $24.2 billion in Q4 2024 and $26.2 billion in Q4 2023.